A Abraxis Research Trademark Details

A Abraxis Research was registered on Tuesday, December 22, 2009 and is currently owned by Abraxis Bioscience, LLC under the registration number 3730111 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 7 years ago on Friday, July 29, 2016, according to the United State Patent & Trademark Office
Word Mark A Abraxis Research
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Abraxis Bioscience, LLC of Los Angeles, CA

View all trademarks for Abraxis Bioscience, LLC
Other Trademarks for Abraxis Bioscience, LLC

Previous Owners

Abraxis Bioscience, Inc. of Los Angeles, CA

View all trademarks for Abraxis Bioscience, Inc.
Other Trademarks for Abraxis Bioscience, Inc.
Serial Number 78865115
Registration Number 3730111
Status Date Friday, July 29, 2016
Filing Date Friday, July 29, 2016
Registration Date Tuesday, December 22, 2009
Attorney Camille M. Miller

Correspondent

Camille M. Miller
COZEN O'CONNOR
One Liberty Place
1650 MARKET ST
PHILADELPHIA PA 19103-3527

Case File Statements

Indication of Colors Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text "Research"
Description of Mark The mark consists in part of a stylized letter "A".
Goods & Services Research and development in the field of pharmaceuticals and drug delivery and technical consultation therewith

Classifications

International Class Codes
042 — Class 42 includes mainly services provided by persons, individually or collectively, in relation to the theoretical and practical aspects of complex fields of activities; such services are provided by members of professions such as chemists, physicists, engineers, computer programmers, etc.
U.S. Class Codes 100, 101
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, July 29, 2016
First Use Anywhere Thursday, August 20, 2009
First Use In Commerce Thursday, August 20, 2009
Primary Code 042

You must be signed in to print.

Once signed in, look for the PDF button.